Stop me if you’ve heard this one before: A miracle new painkiller promises to save us all from the scourge of addiction while effectively treating acute and perhaps even chronic pain. The media goes wild.
This time around, the media is making a fuss about Vertex Pharmaceuticals Incorporated’s suzetrigine, a newly FDA-approved painkiller that also goes by the equally unpronounceable brand name Journavx. Suzetrigine has a highly specific mechanism totally different from the way opioids dull pain.
